Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Debt to Equity (2016 - 2025)

Surgery Partners' Debt to Equity history spans 11 years, with the latest figure at $2.16 for Q4 2025.

  • For Q4 2025, Debt to Equity rose 14.77% year-over-year to $2.16; the TTM value through Dec 2025 reached $2.16, up 14.77%, while the annual FY2025 figure was $2.16, 14.77% up from the prior year.
  • Debt to Equity for Q4 2025 was $2.16 at Surgery Partners, up from $2.06 in the prior quarter.
  • Across five years, Debt to Equity topped out at $2.58 in Q1 2021 and bottomed at $0.86 in Q2 2023.
  • The 5-year median for Debt to Equity is $1.31 (2021), against an average of $1.41.
  • The largest annual shift saw Debt to Equity tumbled 53.93% in 2021 before it surged 105.92% in 2024.
  • A 5-year view of Debt to Equity shows it stood at $1.49 in 2021, then plummeted by 40.25% to $0.89 in 2022, then grew by 2.58% to $0.91 in 2023, then soared by 105.92% to $1.88 in 2024, then rose by 14.77% to $2.16 in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Debt to Equity are $2.16 (Q4 2025), $2.06 (Q3 2025), and $1.13 (Q2 2025).